Antibiotics work for most patients with a bacterial infection, but they may not for all infections. Public health agencies around the world are dealing with the growing challenge of bacterial resistance to antibiotics, which can make these medications ineffective. The Centers for Disease Control and Prevention (CDC) reports that every year at least 2 million… Continue reading Cutting-Edge Technology Sheds Light on Antibiotic Resistance
Category: bacteria
Antibacterial Soap? Skip It
Editor’s note: Recently the FDA issued a ruling prohibiting the marketing of soaps and body washes containing the “antibacterial active ingredients,” including triclosan and triclocarban. This ruling will affect millions of consumers who have used antibacterial soaps in the belief that they guard against illness. Here, the FDA explains its ruling – and what you… Continue reading Antibacterial Soap? Skip It
A Crucial Discovery about Chronic Fatigue Syndrome
For the first time, researchers have identified biological markers of chronic fatigue syndrome in both intestinal bacteria and inflammatory microbial agents in the blood. Chronic fatigue syndrome is condition where normal exertion leads to debilitating fatigue that isn’t alleviated by rest. There are no known triggers, and diagnosis requires lengthy tests administered by an expert.… Continue reading A Crucial Discovery about Chronic Fatigue Syndrome
Progress in The Battle Against Superbugs?
Infections stemming from one of the most troublesome and least understood “superbugs” are increasing at alarming rates, particularly in health-care settings, a new study says. But researchers from Washington University, in St. Louis, say it may be possible to rein in the spread of such infections without needing to develop new antibiotics. So-called “superbugs” are… Continue reading Progress in The Battle Against Superbugs?
A New Antibiotic Could Conquer Superbugs
A newly discovered antibiotic eliminates pathogens without meeting any resistance – and the discovery could pave the way for treating highly resistant infections caused by tuberculosis and MRSA. The discovery, by researchers from Northeastern University, was published in the journal Nature. The antibiotic, called teixobactin, is the first for which there have been no identifiable… Continue reading A New Antibiotic Could Conquer Superbugs